Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /www/christiesalk_113/public/web/wp/wp-includes/functions.php on line 6170
What is ALK? - ALK
Skip to content

ALK for patients

What is ALK-positive lung cancer?

ALK-positive (or ALK+) lung cancer is a type of non-small cell lung cancer. It occurs when a gene called the anaplastic lymphoma kinase (ALK) gene fuses with another gene. This fusion changes the way the signalling works within the cell, causing the cancer cells to continuously divide and replicate.


Who gets ALK+ lung cancer?

ALK+ lung cancer only accounts for about 5% of advanced non-small cell lung cancers**. ALK+ lung cancer can occur in anyone, but tends to be:

  • More common in those who are younger than the average lung cancer patient (>50 years of age, when the average age of lung cancer patients is >70 years) 
  • More common in women
  • More common in never or light smokers
  • More common in those of Asian ethnicity